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polymorphism with premature CAD and tradi‑
tional risk factors for CAD.
Methods Patients We studied 445 white pa‑
tients divided into 2 groups. The first group in‑
cluded 220 patients (59 women and 161 men) 
with angiographically confirmed premature CAD. 
The second group comprised 225 blood donors 
(62 women and 163 men) who served as controls 
with a negative family history of CAD defined 
as the absence of CAD, myocardial infarction, 
or stroke in at least one of the parents. Patients 
with CAD were recruited from the 1st Depart‑
ment of Cardiology at the Upper Silesian Center 
of Cardiology in Katowice and the 1st Depart‑
ment of Cardiac Surgery at the Upper Silesian 
Center of Cardiology in Katowice by the same cli‑
nician. Control individuals were selected among 
blood donors of the regional centers of blood do‑
nation and blood treatment (in Polish, Region‑
alne Centrum Krwiodawstwa i Krwiolecznict‑
wa) in Katowice and Racibórz. The control group 
included only individuals without hyperten‑
sion with a systolic blood pressure of less than 
140 mm Hg and a diastolic blood pressure of less 
than 90 mm Hg on the day of blood collection. 
The levels of blood pressure higher than speci‑
fied above were defined as hypertension.7 Other 
inclusion and exclusion criteria were described 
in detail previously.8 Patients and controls were 
recruited between 2001 and 2006.
The study was approved by the ethics com‑
mittee of the Medical University of Silesia in 
Introduction Coronary artery disease (CAD) 
is a multifactorial condition. The efficacy of treat‑
ment and prevention methods depends on a bet‑
ter understanding of the genetic background of 
CAD as well as patient awareness about control 
of cardiovascular risk factors.1
The  biosynthetic pathway of bile acids is 
the main mechanism of cholesterol catabolism in 
the human body.2 CYP27A1, encoded by the CY-
P27A1 gene (2q35), is a mitochondrial enzyme 
that is expressed in numerous tissues.3 In the liv‑
er, CYP27A1 catalyzes the oxidation of choles‑
terol to 27‑hydroxycholesterol (27‑HC), which is 
an intermediate metabolite of bile acid synthesis.
The role of CYP27A1 in the context of car‑
diovascular diseases remains debatable. Some 
studies have demonstrated that CYP27A1 is 
involved in the mechanism protecting against 
the accumulation of cholesterol in macrophages.4 
On the other hand, 27‑HC may enhance ath‑
erosclerotic plaque formation.5 There are lim‑
ited data on the participation of the CYP27A1 
variants in predisposing to cardiovascular dis‑
eases. So far, it has been demonstrated that 
the g.218805152 A>T polymorphism of the CY-
P27A1 gene (rs4674344) was associated with 
an increased risk of metabolic syndrome and 
a decreased level of high ‑density lipoprotein 
(HDL) cholesterol.6
Because the role of the CYP27A1 polymor‑
phism in the context of CAD risk remains unclear, 
we decided to assess the potential association 
of the CYP27A1 rs4674344 haplotype ‑tagging 
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adjustment for traditional risk factors of CAD 
(male sex, cigarette smoking, hypertension, lip‑
id abnormalities, diabetes mellitus, and over‑
weight or obesity). If the number of individuals 
in the analyzed subgroups was zero, risk ratio 
values (95% CI) were used.
Results Characteristics of the study groups 
The comparison of cases and controls showed 
that patients with CAD had increased total cho‑
lesterol, LDL cholesterol, and triglyceride con‑
centrations as well as higher body mass index 
values. Furthermore, the serum concentration 
of HDL cholesterol was significantly lower in 
CAD patients than in controls.
Association between the CYP27A1 polymorphism 
and coronary artery disease All genotype fre‑
quencies were compatible with the Hardy–Wein‑
berg equilibrium (CAD group, P = 0.999; controls, 
P = 0.66). The analysis did not confirm the hy‑
pothesis about the association between geno‑
types and alleles of the rs4674344 polymor‑
phism and CAD.
Association between the CYP27A1 polymorphism 
and traditional risk factors for coronary  artery 
 disease There were no significant inter‑
actions between the  genotypic variants of 
the rs4674344 polymorphism and traditional 
risk factors for CAD.
Association between the rs4674344 CYP27A1 geno-
types and hypertension The univariate analy‑
sis of the CAD group revealed an association be‑
tween T ‑allele carrier status and hypertension in 
women (χ2 = 5.81; OR, 4.37; 95% CI, 1.26–15.19; 
P = 0.02; TABLE 1).
Katowice (Poland), and informed written con‑
sent was obtained from each participant.
Serum lipid measurement Lipid parameters such 
as total cholesterol, triglycerides, and HDL cho‑
lesterol levels were measured by enzymatic col‑
orimetric methods (Analco, Warsaw, Poland). 
Low ‑density lipoprotein (LDL) cholesterol levels 
were calculated using the Friedewald formula.9
DNA extraction and genotyping Genomic DNA 
was extracted from peripheral leukocytes us‑
ing the MasterPure genomic DNA purification 
kit (Epicenter Technologies, Madison, Wiscon‑
sin, United States). The CYP27A1 polymorphism 
rs4674344 (g.218 805 152 A>T) was genotyped us‑
ing the TaqMan Predesigned SNP Genotyping As‑
say kit (Thermo Fisher Scientific, Foster City, Cali‑
fornia, United States). Genotyping was performed 
using the 7300 Real ‑Time PCR System (Applied 
Biosystems, Foster City, California, United States).
Statistical analysis Statistical analysis was per‑
formed using the Statistica 13.0 (StatSoft, Tul‑
sa, Oklahoma, United States) software. The Sha‑
piro–Wilk test was used to check the normality 
of distribution of quantitative data. Compari‑
son was performed by the Mann–Whitney test 
(nonnormal distribution) or the t test (normal 
distribution). Allele frequencies were deduced 
from the genotype distributions. Hardy–Wein‑
berg equilibrium testing as well as comparisons 
of genotypes and allele frequencies between cas‑
es and control individuals were calculated using 
the χ2 test. Statistical significance was accepted 
at a P value of less than 0.05. Odds ratios (ORs) 
with 95% CIs were computed using univariate 
and multiple logistic regression analysis after 
TABLE 1 Genotype distribution of the rs4674344 polymorphism in patients with and without hypertension
Genotype variant Hypertension No hypertension χ2 P value
Both sexes
Number 125 95 – –
AT + TT 99 (79.2) 65 (68.42) 3.3 0.07
AA 26 (20.8) 30 (31.58) – –
Women
Number 43 16 – –
AT + TT 35 (81.4) 8 (50) 5.81 0.02
AA 8 (18.6) 8 (50) –
Men
Number 82 79 – –
AT + TT 64 (78.05) 57 (72.15) 0.75 0.39
AA 18 (21.95) 22 (27.85) – –
Data are presented as number (percentage) unless otherwise indicated.
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Discussion In our current study, we did not 
find an association between the rs4674344 poly‑
morphic variant of the CYP27A1 gene and the risk 
of CAD in the Polish population. The analysis 
showed an association of the T ‑allele carrier sta‑
tus with hypertension in the subgroup of wom‑
en with CAD. There are no data on the effect of 
the rs4674344 polymorphism on the CYP27A1 
gene expression. However, available reports in‑
dicate that an elevated CYP27A1 expression may 
increase the synthesis of 27‑HC. In an animal 
model, this metabolite induced the expression of 
angiotensin I–converting enzyme and angioten‑
sinogen.10 Earlier reports also indicated a positive 
association between the expression of CYP27A1 
and the synthesis of marinobufagenin, an endog‑
enous cardiotonic steroid acting as an endogenous 
inhibitor of Na+/K+–adenosine triphosphatase.11 
The decrease in the activity of Na+/K+–adenosine 
triphosphatase leads to an increase in the intracel‑
lular calcium concentration and, as a consequence, 
an increase in myocardial contractility and arte‑
rial contraction. The described pathomechanism 
can lead to hypertension.12 Another study found 
that 27‑HC acted antagonistically on the estro‑
gen receptor, inhibiting estrogen ‑dependent syn‑
thesis of nitric oxide in arterial endothelial cells. 
This leads to a reduction of smooth muscle cell 
relaxation in the arterial wall, thus increasing 
the risk of hypertension and cardiovascular dis‑
eases.13 The effect of 27‑HC on estrogen receptors 
may also explain why the association of the CY-
P27A1 gene polymorphism with hypertension was 
observed only in the female subgroup. Umetani 
et al13 suggested that under conditions in which 
the 27‑HC level is elevated relative to the estro‑
gen level (eg, postmenopausal period or hypercho‑
lesterolemia), the protective effect of estrogens is 
reduced. Most of the women included in the cur‑
rent study were in the perimenopausal age and 
suffered from hypercholesterolemia, which may 
have increased the risk of hypertension.
To our knowledge, the  association of 
the rs4674344 polymorphism with hyperten‑
sion has previously been studied only in a Tai‑
wanese population.6 The obtained results were 
in line with our findings; however, the former 
study was performed solely in men.
In conclusion, the  rs4674344 polymor‑
phism of the CYP27A1 gene potentially modi‑
fies the susceptibility to hypertension in Pol‑
ish women with CAD.
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